Patents by Inventor Damien Portevin

Damien Portevin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Phosphorylated dendrimers as antiinflammatory drugs
    Patent number: 10106565
    Abstract: Dendrimers with monophosphonic or bisphosphonic terminations for the treatment of inflammatory diseases.
    Type: Grant
    Filed: July 1, 2013
    Date of Patent: October 23, 2018
    Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), UNIVERSITE PAUL SABATIER (TOULOUSE III)
    Inventors: Mary Poupot, Remy Poupot, Jean-Jacques Fournie, Damien Portevin, Severine Fruchon, Jean-Luc Davignon, Cedric-Olivier Turrin, Anne-Marie Caminade, Jean-Pierre Majoral, Olivier Rolland
  • PHOSPHORYLATED DENDRIMERS AS ANTIINFLAMMATORY DRUGS
    Publication number: 20130336997
    Abstract: Dendrimers with monophosphonic or bisphosphonic terminations for the treatment of inflammatory diseases.
    Type: Application
    Filed: July 1, 2013
    Publication date: December 19, 2013
    Applicant: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Mary POUPOT, Remy POUPOT, Jean-Jacques FOURNIE, Damien PORTEVIN, Severine FRUCHON, Jean-Luc DAVIGNON, Cedric-Olivier DAVIGNON, Anne-Marie CAMINADE, Jean-Pierre MAJORAL, Oliver ROLLAND
  • USE OF PKS 13 PROTEIN CODING FOR CONDENSASE OF MYCOLIC ACIDS OF MYCOBACTERIA AND RELATED STRAINS AS AN ANTIBIOTICS TARGET
    Publication number: 20100267112
    Abstract: The invention relates to a novel enzyme involved in the biosynthesis of mycolic acids and to the use thereof for the screening of antibiotics, especially antimycobacterials. The invention more particularly relates to the Pks13 protein which catalyzes Claisen condensation or malonic condensation in mycolates between an acyl-CoA molecule or an acyl-AMP molecule and an acylmalonyl-CoA molecule to form an intermediate ?-cEto acyl or ?-cEto ester.
    Type: Application
    Filed: September 29, 2008
    Publication date: October 21, 2010
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE PARIS SUD XI
    Inventors: CHRISTOPHE GUILHOT, MAMADOU DAFFE, CHRISTINE HOUSSIN, DAMIEN PORTEVIN, CÉLIA DE SOUSA
  • PHOSPHORYLATED DENDRIMERS AS ANTIINFLAMMATORY DRUGS
    Publication number: 20100173871
    Abstract: A method for treating inflammatory diseases through an anti-inflammatory type activation of monocytes, the method includes the administration to a patient in need thereof of an effective quantity of at least one dendrimer with mono- or biphosphonic terminations.
    Type: Application
    Filed: August 1, 2008
    Publication date: July 8, 2010
    Applicant: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Mary Poupot, Remy Poupot, Jean-Jacques Fournie, Damien Portevin, Severine Fruchon, Jean-Luc Davignon, Cedric-Olivier Davignon, Anne-Marie Caminade, Jean-Pierre Majoral, Oliver Rolland
  • Use of pks 13 protein coding for condensase of mycolic acids of mycobacteria and related strains as an antibiotics target
    Publication number: 20070196889
    Abstract: The invention relates to a novel enzyme involved in the biosynthesis of mycolic acids and to the use thereof for the screening of antibiotics, especially antimycobacterials. The invention more particularly relates to the Pks13 protein which catalyzes Claisen condensation or malonic condensation in mycolates between an acyl-CoA molecule or an acyl-AMP molecule and an acylmalonyl-CoA molecule to form an intermediate ?-cEto acyl or ?-cEto ester.
    Type: Application
    Filed: September 6, 2004
    Publication date: August 23, 2007
    Inventors: Christophe Guilhot, Mamadou Daffe, Christine Houssin, Damien Portevin, Celia De Sousa